Susquehanna Fundamental Investments, LLC Atossa Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $63,230 - $87,905	-77,110 Reduced 68.91%	34,788 $29,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $19,999 - $31,351	-18,018 Reduced 13.87%	111,898 $140,000
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $55,945 - $114,338	34,966 Added 36.83%	129,916 $208,000
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $274,405 - $607,680	94,950 New	94,950 $310,000
Q4 2020 Feb 16, 2021	SELL	$0.85 - $2.43 $14,365 - $41,067	-16,900 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.98 - $4.35 $33,462 - $73,515	16,900 New	16,900 $41,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.